RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $280

Insulet Corporation

Insulet Corporation

PODD

0.00

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ: PODD) with a Outperform and lowers the price target from $325 to $280.